Market Place
Sourcing Support
All News #Library
Quality
Granules India’s Vizag facility completes US FDA inspection with zero 483
15 Apr 2024 //
EXPRESSPHARMA
Granules Pharma Successfully Completes USFDA (PADE) Inspection Zero Observation
04 Aug 2023 //
PRESS RELEASE
Successfully Completes Two US FDA Audits of Two Weeks Vizag Zero Observations
30 Jun 2023 //
PRESS RELEASE
GCH concluded U S FDA audit
21 Mar 2023 //
PRESS RELEASE
USFDA issues form-483 with three observations to Granules India`s Telangana unit
16 Jan 2023 //
CNBCTV18
Granules Pharma Recalls Diabetes Drug Metformin HCI Extended-Release Tablets
07 Jul 2020 //
RTTNEWS
Granules India says `voluntarily` recalling ranitidine tabs
13 Jan 2020 //
ECONOMICTIMES
Granules` arm completes audit with USFDA
11 Dec 2017 //
ECONOMIC TIMES
Granules India Dips 10% on 11 Observations from Portugal Authority
10 Jan 2017 //
BUSINESS STANDARD
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.